Milestone Pharmaceuticals

-$0.01 (-0.18%) As of 7:35 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.

About MIST

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that designed as a rapid-onset nasal spray to be self-administered by patients.

CEO
Joseph G. Oliveto
Employees
28
Headquarters
Montréal, Québec
Founded
2003

MIST Key Statistics

Market Cap
163.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
34.68K
High Today
$5.66
Low Today
$5.34
Open Price
$5.47
Volume
17.92K
52 Week High
$10.45
52 Week Low
$5.09

MIST Earnings

-$0.75
-$0.50
-$0.25
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure